Dexmethylphenidate Hydrochloride
"Dexmethylphenidate Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A methylphenidate derivative, DOPAMINE UPTAKE INHIBITOR and CENTRAL NERVOUS SYSTEM STIMULANT that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
| Descriptor ID |
D064699
|
| MeSH Number(s) |
D02.241.223.601.600.500 D03.383.621.460.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dexmethylphenidate Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Dexmethylphenidate Hydrochloride".
This graph shows the total number of publications written about "Dexmethylphenidate Hydrochloride" by people in this website by year, and whether "Dexmethylphenidate Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dexmethylphenidate Hydrochloride" by people in Profiles.
-
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. J Child Adolesc Psychopharmacol. 2023 03; 33(2):51-58.
-
Extended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder. Clin Neuropharmacol. 2013 Jul-Aug; 36(4):117-21.
-
A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control. J Clin Psychopharmacol. 2012 Oct; 32(5):637-44.
-
Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study. J Child Adolesc Psychopharmacol. 2008 Jun; 18(3):248-56.
-
Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):199-208.
-
A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect. CNS Drugs. 2008; 22(8):693-704.
-
Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting. Psychopharmacol Bull. 2008; 41(1):19-33.
-
Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006 Jun; 16(3):239-51.